Selbyville, Delaware Global Cell Line Development Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2027. Cell Line Development Market Report also covers top key players, porters five forces analysis and market segmentation in detail. This report examines the global Cell Line Development market and provides information regarding the revenue for the period 2020 to 2027.

Global Cell Line Development Market to reach USD 11.51 billion by 2027. Global Cell Line Development Market is valued approximately USD 4.21 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 13.40 % over the forecast period 2020-2027. The cell line is an established cell culture where the cell multiply in apt growth medium and space. The cell lines provide stepwise alternations in the physiology, structure and genetic makeup of the cells. Cell line development requires the discovery of single cell-derived clones that produce high and consistent levels of the target therapeutic protein.

Request a sample of this premium report at:

Cell lines are one of the chief tools used in research for studying the effects of drugs and toxic compounds on the cells , the biochemistry and normal physiology of cells, drug screening and development and large scale manufacturing of biological compounds. The application for cell lines includes research, bioproduction and diagnostics drives the market growth. Also, increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period. Further, increasing prevalence of autoimmune diseases and cancer is likely to increase the demand for accurate and cost-effective treatment options which is expected to render a positive impact on market growth. Moreover, rising vaccine production and growing demand for biosimilars foster the market growth. As in September 2020, Slentim launched a new workflow for single cell cloning of stem cells. the combination of Solentium’s VIPS instrument and new MatriClone Matrix demonstrates a 4 to 5- fold improvement in cloingcloning efficiency. While in the Same month, Octapharma announced to have selected Genedata’s Selector as its Central computational platform to streamline genomics- based cell line development and cell culture optimization workflow. However, High capital cost impedes the growth of the market over the forecast period of 2020-2027. Although, high investments in R&D presents a lucrative opportunity for the market.

The regional analysis of global Cell Line Development market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the large base of biopharmaceutical companies and research and academic institutes in the region along with swelling research programs. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rapidly improving health care facilities would create lucrative growth prospects for the Cell Line Development market across Asia-Pacific region.

Major market player included in this report are:

American Type Culture Collection (ATCC)

Lonza Group AG

Thermo Fisher Scientific Inc

GE Healthcare

Sigma-Aldrich Corporation

Selexis SA

European Collection of Cell Cultures (ECACC)

Corning, Inc

WuXi AppTec, Inc

Sartorious AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:




By Type:

Primary Cell Lines

Continuous Cell Lines


Recombinant Cell Lines

By Application:


Tissue Engineering & Regenerative medicine

Toxicity Testing


Drug Discovery

By Region:

North America










For More Details on this Report At:

About Us:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company’s core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Market Study Report LLC

4 North Main Street,

Selbyville, Delaware 19975


Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150

Email: [email protected]



Leave a comment

Your email address will not be published. Required fields are marked *